June 05, 2017

Nominations now open for the Early Career Research Award

Future Science OA opens nominations for the Early Career Research Award 2017


Future Science Group (FSG) today announced that nominations are now open for the 2017 Early Career Research Award. The award is designed to recognize an outstanding early career researcher working in a biomedical field.


The award has been launched by Future Science OA, the open access biomedical journal published by Future Science Group


“Establishing a career in biomedical research is increasingly difficult, yet brilliant research continues, supported by excellent early career researchers,” commented Francesca Lake, Managing Editor of Future Science OA. “We have launched this award to help support those early career researchers who hold the future of medical research in their hands.”


Your nomination could help your peer, colleague or collaborator receive:

• A prize of £1000

• Membership of Future Science OA’s Young Ambassador panel, giving them the opportunity to contribute to the future of Future Science OA, help support other early career researchers, and publish open access in the journal at no charge.

• Complimentary accelerated publication (publication within 6 weeks, subject to acceptance) of their next manuscript in Future Science OA

• A webinar to showcase their work

• A featured interview in the journal


The nominee must be within the first 5 years of their first career position, and can be selected from academia or industry. The winner will be selected by an Editorial Board panel, and the wider biomedical community.


For further details and to submit your nomination, please click the following link:


Nominations close: Thursday 29th June 2017






About Future Science OA


Launched in March 2015, Future Science OA is the inaugural gold open access journal from Future Science Group. It publishes articles covering research of application to human health, and utilizes a CC-BY license. Future Science OA embraces the importance of publishing all good-quality research with the potential to further the progress of medical science. Negative and early-phase research will be considered. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis.



About Future Science Group


Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG’s portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine. The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.

© 2019 Future Science Group

Unitec House, 2 Albert Place,

London, N3 1QB, UK

Tel: +44 (0)20 8371 6090

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle